May 21 (Reuters) - Medical device maker Medtronic MDT.N plans to separate its diabetes business into a stand-alone company, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.